CAS 274901-16-5
:Vildagliptine
- (-)-(2S)-1-[[(3-Hydroxytricyclo[3.3.1.1[3,7]]dec-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile
- (2S)-1-[2-[(3-Hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile
- (2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.1<sup>3,7</sup>]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile
- (2S)-1-[N-(3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl)glycyl]pyrrolidine-2-carbonitrile
- (3R)-3-amino-1-[6-(trifluoromethyl)-3,4-dihydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one phosphate (1:1)
- (S)-1-[2-[(3-Hydroxyadamant-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile
- 2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.1<sup>3,7</sup>]dec-1-yl)amino]acetyl]-, (2S)-
- 2-Pyrrolidinecarbonitrile, 1-[[(3-hydroxytricyclo[3.3.1.1<sup>3,7</sup>]dec-1-yl)amino]acetyl]-, (2S)-
- Dsp 7238
- Galvus
- Jalra
- Laf 237
- Nvp-Laf 237
- Vidagliptin
- Xiliarx
- 2-Pyrrolidinecarbonitrile, 1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-
- Vildagliptin
- 2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-
- Voir plus de synonymes
Vildagliptin ((2S)-1-[[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C17H25N3O2Masse moléculaire :303.194682-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-
CAS :Formule :C17H25N3O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :303.3993Ref: IN-DA002TWS
1g25,00€5g65,00€10g90,00€1kg330,00€25g113,00€50g194,00€5kgÀ demander100g239,00€10kgÀ demander10mg24,00€Vildagliptin
CAS :Vildagliptin (LAF237), an oral DPP-4 inhibitor with hypoglycemic effects, is metabolized and excreted in urine.Formule :C17H25N3O2Degré de pureté :97.81% - >99.99%Couleur et forme :White Crystalline PowderMasse moléculaire :303.40Vildagliptin
CAS :Formule :C17H25N3O2Degré de pureté :≥ 98.0%Couleur et forme :White to off-white powderMasse moléculaire :303.40Vildagliptin
CAS :Formule :C17H25N3O2Couleur et forme :White To Off-White SolidMasse moléculaire :303.41Vildagliptin
CAS :Formule :C17H25N3O2Degré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :303.41Vildagliptin Impurity 13
CAS :Formule :C24H33N5O3Couleur et forme :White To Off-White SolidMasse moléculaire :439.56N-Nitroso-Vildagliptin
CAS :Produit contrôléFormule :C17H24N4O3Couleur et forme :NeatMasse moléculaire :332.4Vildagliptin
CAS :Produit contrôléStability Hygroscopic
Applications Glyptins are class of oral anti-hyperglycemic agents that inhibit dipeptidyl peptidase 4 (DPP-4), which can act as a serine exopeptidase. Aside from their use in type 2 diabetes, gliptins have positive cardiovascular and anti-inflammtatory effects. Antidiabetic.
References Ahren, B., et al.: J. Clin. Endocrinol. Metab., 89, 2078 (2004), Ahren, B., et al.: Diabetes Care, 27, 2874 (2004), Barlocco, D., et al.: Curr. Opin. Invest. Drugs, 5, 1094 (2004),Formule :C17H25N3O2Couleur et forme :WhiteMasse moléculaire :303.4Vildagliptin
CAS :Dipeptidyl peptidase 4 inhibitor
Formule :C17H25N3O2Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :303.4 g/molDehydroxy Vildagliptin
CAS :Produit contrôléApplications Dehydroxy Vildagliptin is the impurity of Glyptins(V305000) which are class of oral anti-hyperglycemic agents that inhibit dipeptidyl peptidase 4 (DPP-4), which can act as a serine exopeptidase. Aside from their use in type 2 diabetes, gliptins have positive cardiovascular and anti-inflammtatory effects. Antidiabetic.
References Ahren, B., et al.: J. Clin. Endocrinol. Metab., 89, 2078 (2004), Ahren, B., et al.: Diabetes Care, 27, 2874 (2004), Barlocco, D., et al.: Curr. Opin. Invest. Drugs, 5, 1094 (2004),Formule :C17H25N3OCouleur et forme :NeatMasse moléculaire :287.4Vildagliptin-13C5
CAS :Produit contrôléFormule :C5C12H25N3O2Couleur et forme :NeatMasse moléculaire :308.363Vildagliptin - Bio-X ™
CAS :Vildagliptin is an antihyperglycemic agent that is used for the management of type 2 diabetes mellitus. This drug is a dipeptidyl peptidase 4 inhibitor and prevents the degradation of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This leads to improved glycemic control.
Formule :C17H25N3O2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :303.4 g/mol











